| Year |
Citation |
Score |
| 2023 |
Tao Y, Budhipramono A, Huang J, Fang M, Xie S, Kim J, Khivansara V, Dominski Z, Tong L, De Brabander JK, Nijhawan D. Anticancer benzoxaboroles block pre-mRNA processing by directly inhibiting CPSF3. Cell Chemical Biology. PMID 37967558 DOI: 10.1016/j.chembiol.2023.10.019 |
0.306 |
|
| 2005 |
Lin H, Monaco G, Sun T, Ling X, Stephens C, Xie S, Belmont J, Arlinghaus R. Bcr-Abl-mediated suppression of normal hematopoiesis in leukemia. Oncogene. 24: 3246-56. PMID 15735695 DOI: 10.1038/Sj.Onc.1208500 |
0.518 |
|
| 2002 |
Xie S, Lin H, Sun T, Arlinghaus RB. Jak2 is involved in c-Myc induction by Bcr-Abl. Oncogene. 21: 7137-46. PMID 12370803 DOI: 10.1038/Sj.Onc.1205942 |
0.569 |
|
| 2002 |
Hawk N, Sun T, Xie S, Wang Y, Wu Y, Liu J, Arlinghaus RB. Inhibition of the Bcr-Abl oncoprotein by Bcr requires phosphoserine 354. Cancer Research. 62: 386-90. PMID 11809685 |
0.522 |
|
| 2001 |
Xie S, Wang Y, Liu J, Sun T, Wilson MB, Smithgall TE, Arlinghaus RB. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation. Oncogene. 20: 6188-95. PMID 11593427 DOI: 10.1038/Sj.Onc.1204834 |
0.567 |
|
| 1997 |
Xie S, Price JE, Luca M, Jean D, Ronai Z, Bar-Eli M. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells. Oncogene. 15: 2069-75. PMID 9366524 DOI: 10.1038/Sj.Onc.1201358 |
0.411 |
|
| 1996 |
Wilson-Rawls J, Xie S, Liu J, Laneuville P, Arlinghaus RB. P210 Bcr-Abl interacts with the interleukin 3 receptor beta(c) subunit and constitutively induces its tyrosine phosphorylation. Cancer Research. 56: 3426-30. PMID 8758906 |
0.533 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2013 |
Kwon I, Kato M, Xiang S, Wu L, Theodoropoulos P, Mirzaei H, Han T, Xie S, Corden JL, McKnight SL. Phosphorylation-regulated binding of RNA polymerase II to fibrous polymers of low-complexity domains. Cell. 155: 1049-60. PMID 24267890 DOI: 10.1016/J.Cell.2013.10.033 |
0.299 |
|
| 2016 |
Wallace EM, Rizzi JP, Han G, Wehn PM, Cao Z, Du X, Cheng T, Czerwinski RM, Dixon DD, Goggin BS, Grina JA, Halfmann MM, Maddie MA, Olive SR, Schlachter ST, ... ... Xie S, et al. A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma. Cancer Research. 76: 5491-500. PMID 27635045 DOI: 10.1158/0008-5472.Can-16-0473 |
0.24 |
|
| 2007 |
Lee J, Xu Y, Chen Y, Sprung R, Kim SC, Xie S, Zhao Y. Mitochondrial phosphoproteome revealed by an improved IMAC method and MS/MS/MS. Molecular & Cellular Proteomics : McP. 6: 669-76. PMID 17208939 DOI: 10.1074/Mcp.M600218-Mcp200 |
0.208 |
|
| 2012 |
Han TW, Kato M, Xie S, Wu LC, Mirzaei H, Pei J, Chen M, Xie Y, Allen J, Xiao G, McKnight SL. Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies. Cell. 149: 768-79. PMID 22579282 DOI: 10.1016/J.Cell.2012.04.016 |
0.207 |
|
| 2012 |
Kato M, Han TW, Xie S, Shi K, Du X, Wu LC, Mirzaei H, Goldsmith EJ, Longgood J, Pei J, Grishin NV, Frantz DE, Schneider JW, Chen S, Li L, et al. Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell. 149: 753-67. PMID 22579281 DOI: 10.1016/J.Cell.2012.04.017 |
0.184 |
|
| 2018 |
Wehn PM, Rizzi JP, Dixon DD, Grina J, Schlachter ST, Wang B, Xu R, Yang H, Du X, Han G, Wang K, Cao Z, Cheng T, Czerwinski RM, Goggin BS, ... ... Xie S, et al. Design and Activity of Specific Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitors for the Treatment of Clear Cell Renal Cell Carcinoma: Discovery of Clinical Candidate ( S)-3-((2,2-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385). Journal of Medicinal Chemistry. PMID 30289716 DOI: 10.1021/Acs.Jmedchem.8B01196 |
0.16 |
|
| 2019 |
Xu R, Wang K, Rizzi JP, Huang H, Grina JA, Schlachter ST, Wang B, Wehn PM, Yang H, Dixon DD, Czerwinski RM, Du X, Ged EL, Han G, Tan H, ... ... Xie S, et al. 3-[(1 S,2 S,3 R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma. Journal of Medicinal Chemistry. PMID 31282155 DOI: 10.1021/Acs.Jmedchem.9B00719 |
0.152 |
|
| 2023 |
Nguyen TP, Fang M, Kim J, Wang B, Lin E, Khivansara V, Barrows N, Rivera-Cancel G, Goralski M, Cervantes CL, Xie S, Peterson JM, Povedano JM, Antczak MI, Posner BA, et al. Inducible mismatch repair streamlines forward genetic approaches to target identification of cytotoxic small molecules. Cell Chemical Biology. PMID 37607550 DOI: 10.1016/j.chembiol.2023.07.017 |
0.14 |
|
| 2023 |
Nguyen TP, Fang M, Kim J, Wang B, Lin E, Khivansara V, Barrows N, Rivera-Cancel G, Goralski M, Cervantes CL, Xie S, Peterson JM, Povedano JM, Antczak MI, Posner BA, et al. Inducible mismatch repair streamlines forward genetic approaches to target identification of cytotoxic small molecules. Biorxiv : the Preprint Server For Biology. PMID 36865268 DOI: 10.1101/2023.02.21.529401 |
0.139 |
|
| 2020 |
Macias D, Moore S, Crosby A, Southwood M, Du X, Tan H, Xie S, Vassallo A, Wood AJ, Wallace EM, Cowburn AS. Targeting HIF2α-ARNT hetero-dimerisation as a novel therapeutic strategy for Pulmonary Arterial Hypertension. The European Respiratory Journal. PMID 32972983 DOI: 10.1183/13993003.02061-2019 |
0.131 |
|
| 2010 |
Pieper AA, Xie S, Capota E, Estill SJ, Zhong J, Long JM, Becker GL, Huntington P, Goldman SE, Shen CH, Capota M, Britt JK, Kotti T, Ure K, Brat DJ, et al. Discovery of a proneurogenic, neuroprotective chemical. Cell. 142: 39-51. PMID 20603013 DOI: 10.1016/J.Cell.2010.06.018 |
0.125 |
|
| 1997 |
Huang S, Gershenwald JE, Luca M, Gutman M, Xie S, Bar-Eli M. Molecular mechanism of melanoma metastasis Melanoma Research. 7: S59. DOI: 10.1097/00008390-199706001-00206 |
0.046 |
|
| Hide low-probability matches. |